Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease.

Journal of Alzheimer's disease : JAD | 2018

Recent investigations have demonstrated an important role of gut microbiota (GM) in the pathogenesis of Alzheimer's disease (AD). GM modulates a host's health and disease by production of several substances, including lipopolysaccharides (LPS) and short-chain fatty acids (SCFAs), among others. Diet can modify the composition and diversity of GM, and ingestion of a healthy diet has been suggested to lower the risk to develop AD. We have previously shown that bioactive food (BF) ingestion can abate neuroinflammation and oxidative stress and improve cognition in obese rats, effects associated with GM composition. Therefore, BF can impact the gut-brain axis and improved behavior. In this study, we aim to explore if inclusion of BF in the diet may impact central pathological markers of AD by modulation of the GM. Triple transgenic 3xTg-AD (TG) female mice were fed a combination of dried nopal, soy, chia oil, and turmeric for 7 months. We found that BF ingestion improved cognition and reduced Aβ aggregates and tau hyperphosphorylation. In addition, BF decreased MDA levels, astrocyte and microglial activation, PSD-95, synaptophysin, GluR1 and ARC protein levels in TG mice. Furthermore, TG mice fed BF showed increased levels of pGSK-3β. GM analysis revealed that pro-inflammatory bacteria were more abundant in TG mice compared to wild-type, while BF ingestion was able to restore the GM's composition, LPS, and propionate levels to control values. Therefore, the neuroprotective effects of BF may be mediated, in part, by modulation of GM and the release of neurotoxic substances that alter brain function.

Pubmed ID: 30475761 RIS Download

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phospho-Tau (Thr231) Monoclonal Antibody (AT180) (antibody)

RRID:AB_223649

This monoclonal targets Phospho-Tau (Thr231)

View all literature mentions

SIRT1 (H-300) (antibody)

RRID:AB_2188346

This polyclonal targets SIRT1

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

anti-FFAR3 antibody (antibody)

RRID:AB_2732033

This polyclonal targets FFAR3

View all literature mentions

Phospho-Tau (Thr212, Ser214) Monoclonal Antibody (AT100) (antibody)

RRID:AB_223652

This monoclonal targets Phospho-Tau (Thr212, Ser214)

View all literature mentions

GluR1 [E308] antibody (antibody)

RRID:AB_10619776

This monoclonal targets GluR1 [E308] antibody

View all literature mentions

Phospho-GSK-3alpha/beta (Ser21/9) Antibody (antibody)

RRID:AB_329830

This polyclonal targets Phospho-GSK-3alpha/beta (Ser21/9)

View all literature mentions

Arc (C-7) (antibody)

RRID:AB_626696

This monoclonal targets ARC

View all literature mentions

B6;129-Tg(APPSwe,tauP301L)1Lfa Psen1tm1Mpm/Mmjax (organism)

RRID:MMRRC_034830-JAX

Mus musculus with name B6;129-Tg(APPSwe,tauP301L)1Lfa Psen1tm1Mpm/Mmjax from MMRRC.

View all literature mentions

B6129SF1/J (organism)

RRID:IMSR_JAX:101043

Mus musculus with name B6129SF1/J from IMSR.

View all literature mentions

Phospho-Tau (Thr231) Monoclonal Antibody (AT180) (antibody)

RRID:AB_223649

This monoclonal targets Phospho-Tau (Thr231)

View all literature mentions

SIRT1 (H-300) (antibody)

RRID:AB_2188346

This polyclonal targets SIRT1

View all literature mentions

Phospho-Tau (Thr212, Ser214) Monoclonal Antibody (AT100) (antibody)

RRID:AB_223652

This monoclonal targets Phospho-Tau (Thr212, Ser214)

View all literature mentions

Arc (C-7) (antibody)

RRID:AB_626696

This monoclonal targets ARC

View all literature mentions

B6129SF1/J (organism)

RRID:IMSR_JAX:101043

Mus musculus with name B6129SF1/J from IMSR.

View all literature mentions

B6;129-Tg(APPSwe,tauP301L)1Lfa Psen1tm1Mpm/Mmjax (organism)

RRID:MMRRC_034830-JAX

Mus musculus with name B6;129-Tg(APPSwe,tauP301L)1Lfa Psen1tm1Mpm/Mmjax from MMRRC.

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

Phospho-GSK-3alpha/beta (Ser21/9) Antibody (antibody)

RRID:AB_329830

This polyclonal targets Phospho-GSK-3alpha/beta (Ser21/9)

View all literature mentions

GluR1 [E308] antibody (antibody)

RRID:AB_10619776

This monoclonal targets GluR1 [E308] antibody

View all literature mentions

anti-FFAR3 antibody (antibody)

RRID:AB_2732033

This polyclonal targets FFAR3

View all literature mentions